Ernexa Therapeutics announced that Sandra Gurrola will resign as Senior Vice President of Finance, effective July 3, 2026, and will provide limited transition support.
| IndividualSandra Gurrola | RoleSenior Vice President of Finance | Type of ChangeResigned | Effective DateJuly 3, 2026 | ReasonNot a result of any disagreement with the Company on operations, policies or practices | Replacement InfoCompany has initiated a search; using outside support until successor appointed | Background DetailsWill provide transition assistance up to 10 hours/week through filing of Form 10-Q for quarter ended June 30, 2026; compensation for transition services not yet determined | Board/Committee Role ChangesNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.